Steve Deitsch

Steve Deitsch Email and Phone Number

Chief Financial Officer | Med-Tech Executive | Board Member @ OrganOx
Steve Deitsch's Location
New York City Metropolitan Area, United States, United States
Steve Deitsch's Contact Details
About Steve Deitsch

CFO | BOARD MEMBERBroad and deep executive leadership experience with both public and privately held companies.EXCEPTIONAL TRACK RECORDCurrently* Paragon 28 CFO (NYSE "FNA") since September 2020. FNA completed its $1.2 billion IPO on October 15, 2021.Previously * BioScrip CFO (formerly NASDAQ “BIOS”), billion dollar+ publicly traded healthcare services company. Increased shareholder value more than 3X and completed successful exit and merger with Option Care Health (NASDAQ “OPCH”) in August 2019.* Lanx CFO and EMEA GM, leading privately held spinal implant medical device company. Led successful sale to Biomet in 2013. Joined Biomet as CAO/Controller and later Group CFO.* Zimmer Biomet various executive roles, including two years based in Zurich, Switzerland.* Deloitte and Ernst & Young. Served global clients as audit executive.MULTI-DIMENSIONAL* Strategic, commercial & operational acumen; growth orientation; investor relations; public and private capital markets; financial discipline.COLLABORATIVE & EMPOWERING LEADERSHIP* Retain or hire best talent; empower teams; hold teams accountable.

Steve Deitsch's Current Company Details
OrganOx

Organox

View
Chief Financial Officer | Med-Tech Executive | Board Member
Steve Deitsch Work Experience Details
  • Organox
    Chief Financial Officer
    Organox Apr 2024 - Present
    Oxford, Oxfordshire, Gb
    OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Our leading product, the metra®, harnesses patented normothermic machine perfusion technology to preserve donor livers for up to 24 hours prior to transplant.
    View
  • Aclarion
    Board Member
    Aclarion Apr 2022 - Present
    Broomfield, Colorado, Us
    Aclarion (NASDAQ "ACON") is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes and return patients to full, pain-free lives. The company’s first solution will address unmet needs in the low back and neck pain market. To learn more, visit www.aclarion.com.
    View
  • Auddia
    Board Member
    Auddia Feb 2021 - Present
    Boulder, Co, Us
    Auddia (Nasdaq "AUUD") is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia offers two industry firsts -- the ability to listen to any AM/FM radio station with added personalized content and no commercials as well as podcasts with an interactive digital feed that supports deeper stories and delivers digital revenue to podcasters. Both offerings address large and rapidly growing audiences with strong purchase intent. For more information, visit: www.auddia.com
    View
  • Paragon 28
    Chief Financial Officer
    Paragon 28 Sep 2020 - Apr 2024
    Englewood, Colorado, Us
    Paragon 28® (NYSE "FNA") is a leading orthopedic medical device. Led successful NYSE IPO in October 2021 with enterprise valuation in excess of $1 billion. Revenue doubled during tenure to more $218mm in 2023.
    View
  • Bioscrip, Inc., (Formerly Nasdaq
    Chief Financial Officer
    Bioscrip, Inc., (Formerly Nasdaq "Bios") Now A Part Of Option Care Health (Nasdaq "Opch") Apr 2017 - Aug 2019
    Bioscrip was the largest independent provider of home infusion services. Successful merger with Option Care Health in 2019, creating NASDAQ listed "OPCH". Market capitalization increased more than 3X during tenure, with enterprise value ~$1 billion at exit.
  • Coalfire
    Chief Financial Officer
    Coalfire Aug 2015 - Apr 2017
    Greenwood Village, Co, Us
    Coalfire is a global leader in cyber security. Led successful recap with The Carlyle Group and acquisition of The Veris Group.
    View
  • Zimmer Biomet
    Lanx Cfo; Biomet Cao/Corporate Controller;Biomet Group Cfo
    Zimmer Biomet Sep 2009 - Jul 2015
    Warsaw, Indiana, Us
    Zimmer and Biomet merged in 2015 to form Zimmer Biomet. Biomet Group CFO Spine, Bone Healing, and Microfixation: July 2014 through July 2015 (closer of merger with Zimmer).Biomet CAO/Corporate Controller: January 2014 through July 2014. Hired by Biomet after its acquisition of Lanx to lead financial component of planned IPO.Lanx Chief Financial Officer: September 2009 through November 2013. Successful sale to Biomet.
    View
  • Zimmer
    Vice President, Finance, Global Reconstructive & Global Operations
    Zimmer 2007 - 2009
    Warsaw, Indiana, Us
    Led finance and accounting for Zimmer's global reconstructive business (sales ~ $3 billion) and global supply chain.
    View
  • Zimmer
    Vice President, Finance, Europe Middle East & Africa
    Zimmer 2005 - 2007
    Warsaw, Indiana, Us
    Based in Zurich, Switzerland. Completed financial integration of Centerpulse acquisition which quadrupled Zimmer sales in EMEA to $1 billion. Increased profitability, improved financial planning and controls, and built out new EMEA finance leadership team (150+ member finance and accounting team).
    View
  • Zimmer
    Associate Director, Corporate Finance
    Zimmer 2002 - 2005
    Warsaw, Indiana, Us
    Led corporate financial reporting team and processes. Completed purchase accounting, SEC filings, and financial integration activities for $3 billion acquisition of Swiss based Centerpulse.
    View
  • Ey
    Senior Manager
    Ey 2001 - 2002
    London, Gb
    Leading healthcare clients including Eli Lilly and Company, The Cook Group, and Biomet,
    View
  • Lilly Industries, Inc.
    Finance Director
    Lilly Industries, Inc. 1998 - 2000
  • Deloitte
    Manager
    Deloitte 1993 - 1998
    Worldwide, Oo
    View

Steve Deitsch Education Details

  • Ball State University
    Ball State University
    Accounting

Frequently Asked Questions about Steve Deitsch

What company does Steve Deitsch work for?

Steve Deitsch works for Organox

What is Steve Deitsch's role at the current company?

Steve Deitsch's current role is Chief Financial Officer | Med-Tech Executive | Board Member.

What is Steve Deitsch's email address?

Steve Deitsch's email address is st****@****ire.com

What is Steve Deitsch's direct phone number?

Steve Deitsch's direct phone number is +130355*****

What schools did Steve Deitsch attend?

Steve Deitsch attended Ball State University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.